Summary of Significant Accounting Policies Summary of Signficant Accounting Policies (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		12 Months Ended
	Feb. 28, 2014		Feb. 28, 2014		Feb. 22, 2013		Feb. 24, 2012
Accounting Policies [Line Items]
Number of weeks in fiscal year			P53W		P52W		P52W
Fiscal Year [Abstract]
Number of weeks in quarter	P14W		P13W
Cash and Cash Equivalents [Abstract]
Restricted Cash and Cash Equivalents	$ 9.0		$ 9.0		$ 3.5
Workers Compensation [Abstract]
Workers' Compensation Liability	14.6		14.6		15.9
Workers' Compensation Liability, Current	5.0		5.0		4.8
Product Liability [Abstract]
Loss Contingency Accrual, Product Liability, Gross	5.8		5.8		5.3
Employee medical, dental and short term liability [Abstract]
Liability for Claims and Claims Adjustment Expense	2.8		2.8		3.0
Product Warranties [Roll Forward]
Product Warranty Accrual, Beginning of Period			31.1		29.9		31.3
Product Warranty Accrual, Period Increase (Decrease)			16.2		10.7		11.1
Product Warranty Accrual, Preexisting, Increase (Decrease)			(4.6)		0.3		(1.9)
Product Warranty Accrual, Payments			(14.9)		(9.4)		(14.4)
Product Warranty Accrual, Currency Translation, Increase (Decrease)			0.3		0.2		0
Product Warranty Accrual, End of Period	37.3		37.3		31.1		29.9
Product Warranty Accrual, Noncurrent	19.8		19.8		17.0
Environmental Matters [Abstract]
Accrual for Environmental Loss Contingencies, Net	6.6		6.6		5.6
Accrual for Environmental Loss Contingencies, Gross	8.5		8.5		7.2
Accrual for Environmental Loss Contingencies, Discount Rate	3.60%		3.60%		3.20%
Research and Development Expense [Abstract]
Research and Development Expense			35.9		36.0		35.8
Financial Instruments [Abstract]
Debt and Capital Lease Obligations	287.0		287.0		289.0
Balance Sheet Related Disclosures [Abstract]
Foreign Currency Derivatives at Fair Value, Net	(2.9)	[1]	(2.9)	[1]	(0.6)	[1]
Derivative, Notional Amount	122.4		122.4		115.0
Income Statement Related Disclosures [Abstract]
Operating expenses			757.0		727.0		708.3
Other income (expense), net			0.6		(9.7)		(5.3)
Derivative Instruments, Gain (Loss) Recognized in Income, Net			3.6		0.2		(5.2)
Estimate of Fair Value, Fair Value Disclosure [Member]
Balance Sheet Related Disclosures [Abstract]
Foreign Currency Contract, Asset, Fair Value Disclosure	0.3		0.3		1.3
Foreign Currency Contracts, Liability, Fair Value Disclosure	(3.2)		(3.2)		(1.9)
Estimate of Fair Value, Fair Value Disclosure [Member] | Fair Value, Measurements, Recurring [Member]
Cash and Cash Equivalents [Abstract]
Restricted Cash and Cash Equivalents	9.0		9.0		3.5
Balance Sheet Related Disclosures [Abstract]
Foreign Currency Contract, Asset, Fair Value Disclosure	0.3		0.3		1.3
Foreign Currency Contracts, Liability, Fair Value Disclosure	(3.2)		(3.2)		(1.9)
Forward Contracts [Member]
Income Statement Related Disclosures [Abstract]
Cost of Goods Sold			(0.1)		0.2		0.3
Operating expenses			0		0.1		0.1
Other income (expense), net			(3.5)		(0.5)		4.8
Minimum [Member]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Equity Method Investment, Ownership Percentage	20.00%		20.00%
Product Warranties [Roll Forward]
Standard Product Warranty Description			12
Maximum [Member]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Equity Method Investment, Ownership Percentage	50.00%		50.00%
Product Warranties [Roll Forward]
Standard Product Warranty Description			lifetime
Estimate of Fair Value, Fair Value Disclosure [Member]
Financial Instruments [Abstract]
Long-term Debt, Fair Value	$ 327		$ 327		$ 321

[1] The notional amounts of the outstanding foreign exchange forward contracts were $122.4 as of February 28, 2014 and $115.0 as of February 22, 2013.